The current findings corroborate the hypothesis that SHBG may have a role not only as carrier protein for testosterone and a biomarker of metabolic disease, but also as a hepatokine affecting type 2 diabetes [16, 17, 33]. This evidence concerns the gene SHBG and metabolic disease.